Stephanie is the President and CEO of BioCanRx. Stephanie holds more than 20 years of public, government and private sector experience in research and Science & Technology innovation policy. She strives to create partnerships between government, not-for-profits, academia and industry to maximize the impact of research on the lives of those affected by cancer.
Stephanie earned a PhD in Organic Chemistry from McGill University. She is involved with a number of not-for-profit organizations and is a member of the Board of Directors of the Stem Cell Network.